Drug Discovery and Development Industry: Nerviano Medical Sciences S.r.l. – Product Pipeline Review – Q2 2011

• Publication date: July 2012
• Report size: 53 pages

.l. - Product Pipeline Review - Q2 2011” provides a detailed overview on the Nerviano Medical Sciences S.r.l.’s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct’s proprietary databases, Nerviano Medical Sciences S.r.l.’s cor...

.l. - Product Pipeline Review - Q2 2011” provides a detailed overview on the Nerviano Medical Sciences S.r.l.’s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industries Direct’s proprietary databases, Nerviano Medical Sciences S.r.l.’s corporate website, SEC filings, investor presentations and featured press releases, both from Nerviano Medical Sciences S.r.l. and market -specific third party sources, put together by Global Industries Direct’s team.

Scope of the Research

- Nerviano Medical Sciences S.r.l. - Brief Nerviano Medical Sciences S.r.l. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Nerviano Medical Sciences S.r.l. human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Nerviano Medical Sciences S.r.l. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Nerviano Medical Sciences S.r.l.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate Nerviano Medical Sciences S.r.l.’s strategic position with total access to detailed data on its product pipeline.
- Assess the growth opportunities of Nerviano Medical Sciences S.r.l. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Nerviano Medical Sciences S.r.l.’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Nerviano Medical Sciences S.r.l..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Nerviano Medical Sciences S.r.l. and identify potential opportunities in those areas.

Global Drug Discovery And Development Industry

Table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Nerviano Medical Sciences S.r.l. Snapshot 4
Nerviano Medical Sciences S.r.l. Overview 4
Key Information 4
Key Facts 4
Nerviano Medical Sciences S.r.l. – Research and Development Overview 5
Key Therapeutic Areas 5
Nerviano Medical Sciences S.r.l. – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
Nerviano Medical Sciences S.r.l. – Pipeline Products Glance 9
Nerviano Medical Sciences S.r.l. Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Nerviano Medical Sciences S.r.l. – Drug Profiles 10
Nemorubicin 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
Nerviano Medical Sciences S.r.l. - Pipeline Products By Target 11
Nerviano Medical Sciences S.r.l. – Pipeline Products by Route of Administration 12
Nerviano Medical Sciences S.r.l. – Pipeline Products by Molecule Type 13
Nerviano Medical Sciences S.r.l. – Operations and Subsidiaries 14
Head Office 14
Financial Deals Landscape 15
Nerviano Medical Sciences S.r.l., Deals Volume Summary, from 2004 to 2011 15
Nerviano Medical Sciences S.r.l., Merger and Acquisition Deal Summary By Region, from 2004 to 2011 16
Nerviano Medical Sciences S.r.l., Merger and Acquisition Deal Summary, from 2004 to 2011 17
Nerviano Medical Sciences S.r.l. Detailed Deal Summary 18
Nerviano Medical Sciences Enters Into Collaboration With Genentech 18
Nerviano Medical Sciences Enters Into Collaboration With Genentech 20
Indena Enters Into Co-Development Agreement With Nerviano Medical Sciences 21
ChemDiv Extends Co-Development Agreement With Nerviano Medical Sciences 22
Nerviano Medical Enters Into Co-Development Agreement With Bristol-Myers 23
Licensing Agreements 24
Nerviano Medical Enters Into Licensing Agreement With Systems Medicine 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 26
Contact Us 26
Disclaimer 26

List of Tables

Nerviano Medical Sciences S.r.l. – Pipeline by Therapy Area and Indication, 2011 6
Nerviano Medical Sciences S.r.l. – Pipeline by Stage of Development, 2011 7
Nerviano Medical Sciences S.r.l. – Monotherapy Products in Pipeline, 2011 8
Nerviano Medical Sciences S.r.l. - Phase II, 2011 9
Nerviano Medical Sciences S.r.l. - Pipeline By Target, 2011 11
Nerviano Medical Sciences S.r.l. – Pipeline By Route of Administration, 2011 12
Nerviano Medical Sciences S.r.l. – Pipeline By Molecule Type, 2011 13
Nerviano Medical Sciences S.r.l., Merger and Acquisition Deal Summary, from 2004 to 2011 15
Nerviano Medical Sciences S.r.l., Merger and Acquisition Deal Summary by Region, from 2004 to 2011 16
Nerviano Medical Sciences S.r.l., Merger and Acquisition Deal Summary, from 2004 to 2011 17

List of Figures

Nerviano Medical Sciences S.r.l. – Pipeline by Therapy Area and Indication, 2011 6
Nerviano Medical Sciences S.r.l. – Pipeline by Stage of Development, 2011 7
Nerviano Medical Sciences S.r.l. – Monotherapy Products in Pipeline, 2011 8